Network origin in Jonathan Gilbert first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 32 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jonathan Gilbert via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| PFIZER, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Sales & Marketing Corporate Officer/Principal Human Resources Officer | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Microbion Corp.
 Microbion Corp. Pharmaceuticals: MajorHealth Technology Microbion Corp. develops topical microbial therapeutic products. It safeguards human health by overcoming infections, antibiotic resistance, and microbial biofilms with safe, effective anti-infective products. The firm is developing MBN-101 as the first product in a new class for the treatment of antibiotic-resistant and difficult to treat infections. The company was founded by Brett H. Baker and is headquartered in Bozeman, MT. | Pharmaceuticals: Major | Director/Board Member | |
Adimab LLC
 Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | Biotechnology | Director/Board Member | |
PhysIQ, Inc.
 PhysIQ, Inc. Packaged SoftwareTechnology Services PhysIQ, Inc. provides proprietary predictive analytics for human physiology. It designs, develops and commercializes predictive analytics technologies to monitor the health of complex systems. The company was founded by Matt R. Pipke and Gary W. Conkright in 1999 and is headquartered in Naperville, IL. | Packaged Software | Director/Board Member | |
Polaris Growth Management LLC
 Polaris Growth Management LLC Investment ManagersFinance Polaris Partners is an Independent Venture Capital firm founded in 1996 by Stephen D. Arnold, Jonathan A. Flint and Terrance G. McGuire. Polaris Partners is headquartered in Waltham. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Freiburg | College/University | Doctorate Degree | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
| Carleton College | College/University | Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
| Universität zu Köln | College/University | Doctorate Degree | |
| Bridger Capital LLC | Corporate Officer/Principal | ||
| MESOBLAST LIMITED | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Weizmann Institute of Science | College/University | Doctorate Degree | |
| EPIZYME, INC. | Biotechnology | Public Communications Contact Chief Tech/Sci/R&D Officer | |
| HEARTWARE INTERNATIONAL INC | Medical Specialties | General Counsel Human Resources Officer | |
Community Servings, Inc.
 Community Servings, Inc. Services to the Health IndustryHealth Services Community Servings is a non-profit organization that provides food and nutrition programs to individuals and families living with critical and chronic illnesses. It offers meal delivery, nutrition services, and program initiatives, covering: job trainings, international advocacies, social enterprise, and sustainable agriculture. The company was founded in 1989 and is headquartered in Jamaica Plain, MA. | Services to the Health Industry | Director/Board Member | |
| Avastin | Chief Tech/Sci/R&D Officer | ||
| Jewish Big Brothers Big Sisters of Greater Boston | Director/Board Member | ||
| FRACTYL HEALTH, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Eloxx Pharmaceuticals Ltd.
 Eloxx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Eloxx Pharmaceuticals Ltd. provides biopharmaceutical research and development services. The firm specializes in the discovery, development, and commercialization of drug compounds for the treatment of genetic diseases. It focuses on the treatment of diseases caused by nonsense mutations, including Cystic fibrosis, Duchene Muscular Dystrophy, Usher syndrome, Ataxia-telangiectasia, Beta thalassemia, and Tay-Sachs Hurler syndrome. Its focus areas encompass clinical drug development and target drugs discovery programs. The company was founded by Silvia Noiman and Shmuel Tuvia in 2013 and is headquartered in Herzliya, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| Solomon Schechter Day School of Greater Boston | Director/Board Member | ||
| University of San Diego School of Business Administration | College/University | Masters Business Admin | |
Lyndra Therapeutics, Inc.
 Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | Packaged Software | Founder Director/Board Member | |
| KEROS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
CathWorks Ltd.
 CathWorks Ltd. Medical SpecialtiesHealth Technology CathWorks Ltd. develops medical devices for the interventional cardiology market. Its technology is based on processing visual information and automatic multi-layered algorithms. The company was founded by Guy Lavi and Ifat Lavi in 2013 and is headquartered in Raanana, Israel. | Medical Specialties | Director/Board Member | |
| IKENA ONCOLOGY, INC. | Biotechnology | Investor Relations Contact | |
| DECIPHERA PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| ELOXX PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Enclear Therapies, Inc.
 Enclear Therapies, Inc. Pharmaceuticals: MajorHealth Technology Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA. | Pharmaceuticals: Major | Director/Board Member | |
M28 Capital Management LP
 M28 Capital Management LP Investment ManagersFinance M28 Capital Management LP (M28 Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Stamford, Connecticut. The firm was founded by Marc Elia in 2019. M28 Capital provides investment advisory services on a discretionary basis to several private fund clients. | Investment Managers | Founder | |
Volastra Therapeutics, Inc.
 Volastra Therapeutics, Inc. BiotechnologyHealth Technology Volastra Therapeutics, Inc. develops novel therapies for patients with metastatic cancers. The company was founded by Lewis Cantley, Samuel Bakhoum and Olivier Elemento and is headquartered in Boston, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| NUVALENT, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| Sqz Biotechnologies, Inc. | Chief Executive Officer | ||
Inzen Therapeutics, Inc.
 Inzen Therapeutics, Inc. BiotechnologyHealth Technology Part of Sonata Therapeutics, Inc., Inzen Therapeutics, Inc. is discovering and developing a novel class of medicines based on thanokine biology. The company is based in Cambridge, MA. Thanokine biology offers the potential for unprecedented approaches to prevent and treat cancer, fibrotic disorders, immune-inflammatory disorders, metabolic disorders, and degenerative diseases. Inzen's thanokine product platform applies advances in mass spectrometry and machine learning, novel probes, unique assays, genetic and chemical biological technologies to characterize thanokine biology at scale and create drug candidates. Inzen Therapeutics harnesses signals of the cellular microenvironment to treat serious diseases. The company was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability. | Biotechnology | President | |
| DynamiCure Biotechnology LLC | President | ||
Sonata Therapeutics, Inc.
 Sonata Therapeutics, Inc. BiotechnologyHealth Technology Sonata Therapeutics, Inc. is a pioneering private company based in Cambridge, MA that designs single therapeutics to reprogram diseased cells and create curative microenvironments. The company's machine learning-based platform identifies novel insights, targets, and therapeutics across a wide range of disease areas, with a growing pipeline of small molecule drugs and genetic therapeutics. In oncology, Sonata's transformative therapies reprogram cancer cells to release curative signals that reverse immune cell suppression and blockade, empowering the immune system to holistically eradicate tumors and drive cure. Sonata Therapeutics is creating a new class of network medicines™ designed to modulate all the key cell types in a disease microenvironment required to drive disease resolution. The company is also exploring additional therapeutic areas such as fibrosis and tissue regeneration where multicellular networks play a key role. The company has subsidiaries in the United States. The company was founded in 2022 by flagship pioneering, and the CEO is Volker Herrmann. | Biotechnology | Chief Executive Officer | |
Airna, Inc.
 Airna, Inc. Miscellaneous Commercial ServicesCommercial Services Airna, Inc. is an American company that focuses on the discovery and development of RNA editing therapeutics. Airna was founded by Thorsten Stafforst, Jin Billy Li, Tobias Merkle, Paul Vogel. The CEO is Kris Elverum. | Miscellaneous Commercial Services | Director/Board Member |
Statistics
International
| United States | 42 |
| Israel | 5 |
| Germany | 3 |
| Switzerland | 2 |
| France | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 8 |
| Finance | 5 |
| Technology Services | 3 |
| Health Services | 2 |
Operational
| Director/Board Member | 130 |
| Independent Dir/Board Member | 46 |
| Corporate Officer/Principal | 44 |
| Chairman | 26 |
| Undergraduate Degree | 24 |
Most connected contacts
| Insiders | |
|---|---|
| Amy Schulman | 45 |
| Patrick Volkert Vink | 30 |
| Sapna R. Srivastava | 22 |
| Zafrira Avnur | 20 |
| Isaac E. Ciechanover | 16 |
| Garry Nicholson | 16 |
| Alexis Ji | 15 |
| Teri Loxam | 14 |
| Bernard Coulie | 13 |
| Lawrence Knopf | 12 |
| Paul Bolno | 12 |
| Eric Moessinger | 12 |
| Marc Schegerin | 11 |
| Shefali Agarwal | 9 |
| Oliver Rosen | 9 |
- Stock Market
- Insiders
- Jonathan Gilbert
- Company connections
